GENERAL INFORMATION FOR THE 2016 CANADIAN DIGESTIVE DISEASES WEEK™ (CDDW™) SCIENTIFIC SESSIONS: Centre Ice Gala – Sunday February 28 The Gastroenterology Residents in Training (GRIT) Program (by Pull on your favourite hockey jersey, and enjoy the company of fellow invitation only) will be held at the Fairmont Queen Elizabeth. hockey fans as CDDW™ hosts the “Centre Ice Gala”. Treat your taste Registration Desk Hours – Foyer, Conference Level buds to the most exotic stadium cuisine, test out your stick handling Tuesday, February 23 12h00-21h30 skills, and skate the night away with tunes from our own Power Play DJ. Wednesday, February 24 08h00-20h30 Purchase tickets ($100 + tax) online and also at registration on-site. Thursday, February 25 07h00-17h00 CanMEDS ROLES The Scholars’ and Research Topics in Gastrointestinal (GI) Disease CanMEDS is a framework that identifies and describes the abilities Programs (invitation only) will be held at the Fairmont Queen Elizabeth. physicians require to effectively meet the health care needs of the people they serve. These abilities are grouped thematically under seven Registration Desk Hours – Foyer, Conference Level roles: Medical Expert (the integrating role), Communicator, Collaborator, Wednesday, February 24 08h00-20h30 Leader, Health Advocate, Scholar and Professional. The CDDW™ Thursday, February 25 07h00-17h00 program will include CanMEDS roles which will be identified at the All core sessions of CDDW™ will be held at the Fairmont Queen beginning of each session. For more information on these newly revised Elizabeth. Registration Desk hours – Mezzanine Level definitions, visit: Thursday, February 25 17h00-21h00 http://www.royalcollege.ca/portal/page/portal/rc/canmeds/framework. Friday, February 26 07h00-18h30 Saturday, February 27 07h00-18h30 ACCREDITATION Sunday, February 28 07h30-18h30 The CDDW™ Meeting is accredited as a group learning activity (Section Monday, February 29 07h30-14h00 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada (RCPSC) (as the EXHIBIT HOURS conference overall includes at least 25% interactive time). See page 35 The Exhibit and Trade Show will be held in the Le Grand for a listing of credits per session. Financial support for sessions, as Salon/Hochelagas 1-3 and will be open as follows: indicated within the program, is through educational grants. CDDW™ is Friday, February 26 09h30-18h30 in compliance with the CQDPCM (Quebec) Code of Ethics. For more Saturday, February 27 10h30-15h30 information, please go to: http://www.cemcq.qc.ca/en/index_guide.cfm. Sunday, February 28 10h30-15h30 Live educational activities, occurring in Canada, recognized by the RCPSC as Accredited Group Learning Activities (Section 1) are deemed SPEAKER READY ROOM by the European Union of Medical Specialists eligible for ECMEC Please note that all speakers are asked to present themselves at the credits. Speaker Ready Room, Saint Charles, at least two hours before their presentation. Through an agreement between the RCPSC and the American Medical Speaker Ready Room Hours Association, physicians may convert RCPSC MOC credits to AMA PRA Thursday, February 25 17h00-21h00 Category 1 Credits™. Information on the process to convert RCPSC Friday-Sunday, February 26-28 07h00-18h00 MOC credit to AMA credit can be found at Monday, February 29 07h00-14h00 http://www.amaassn.org/go/internationalcme NO presentation preparation/loading for plenary sessions will be The 2016 CDDW™ is endorsed by: permitted to take place in rooms Marquette/Jolliett, Duluth or the Faculty who are American College of Mackenzie. Breakfast and small group presentations may be loaded Gastroenterology Fellows or Masters are identified in those rooms. throughout the program by the * symbol CDDW™ IMPLEMENTATION COMMITTEE Co-Chairs David Armstrong, CAG President Elect Richard Schreiber, CASL President Elect CAG Committee CASL Committee Derek McKay, Past Co-Chair Eberhard Renner, Past Co-Chair Kevin Waschke, Education Hemant Shah, Education François Boudreau, Research Christopher Rose, Research Wallace MacNaughton, Finance Kelly Burak, Finance Paul Sinclair, Executive Director GRIT Course Scholars’ Program Mark Borgaonkar, Geoff Williams Herbert Brill, Saumya Jayakumar Research Topics in GI Disease Gilaad Kaplan, Elena Verdu 1 CDDW™– PROGRAM AT A GLANCE Start FRIDAY February 26 SATURDAY February 27 SUNDAY February 28 MONDAY February 29 Start 07h00▲ 07h00▲ CAG Open Mic 07h30▲ 07h30▲ 08h00▲ Difficult Celiac Barrett's HRS and Difficult H pylori Difficult Cases in Ulcerative 08h00▲ 08h30▲ IBD Community-based GI and AILD Cases Disease Esophagus SBP Cases in CD Therapeutics Colitis 08h30▲ Microbiota Liver Disease Epigenetics 09h00▲ of GI Cancer CASL Paper Innate 09h00▲ Precision Medicine in Luminal Signaling to 2015 Papers Session 1 Mucosal CASL Paper The Future of 09h30▲ Exhibits & Coffee Break Gastroenterology Nerves in Functional Influencing 09h30▲ Immunology Session 2 Hepatology 10h00▲ Disorders Practice 10h00▲ CAG/CCC CASL-CLF Gold Medal Lecture Clinical Inpatient 10h30▲ Student Exhibits & Coffee Break Exhibits & Coffee Break Coffee Break 10h30▲ papers Hepatology 11h00▲ Prizes 11h00▲ Small Group Sessions Small Group Sessions Small Groups 11h30▲ 11h30▲ Exhibits & Lunch (11h30-12h30) 12h00▲ Small Group Sessions Small Group Sessions Small Groups 12h00▲ 12h30▲ 12h30▲ Exhibits & Lunch (12h30-13h30) Exhibits & Lunch (12h30-13h30) Lunch (12h30-13h30) 13h00▲ Cellular 13h00▲ Reprogram Safety Monitoring 13h30▲ 13h30▲ ming Research Research Hepato- Updates in Pediatric The Role of Nutrition in Rapid Fire 2015 Journal Therapeutics in IBD: Past, 14h00▲ Career Aw ard cellular 14h00▲ Cholestasis Gastroenterology Review present and future 14h30▲ Exhibits & Coffee Break Development Lectures Carcinoma 14h30▲ 15h00▲ Exhibits & Coffee Break Exhibits & Coffee Break 15h00▲ Colonic 15h30▲ Video Endoscopy Kopelman 15h30▲ Motility Optimizing Fatty Liver Monitoring Disease New HCV 16h00▲ Lecture Diarrhea and Constipation 16h00▲ Outcomes Activity in IBD Technologies Update 16h30▲ 16h30▲ CASL AGM CAG AGM 17h00▲ McKenna Reception 17h00▲ Aw ards Ceremony 17h30▲ 17h30▲ CDDW™ Opening Reception McKenna Lecture 18h00▲ 18h00▲ 18h30▲ Poster Session 2 18h30▲ 19h00▲ Trainee Mixer Poster Session 1 19h00▲ 19h30▲ 19h30▲ 20h00▲ 20h00▲ Gala Evening AGM annual general meeting; AILD autoimmune liver disease; CCC Crohn’s and Colitis Canada; CD Crohn’s disease; CLF Canadian Liver Foundation; GI gastrointestinal; H pylori Helicobacter pylori; HCV hepatitis C virus; HRS hepatorenal syndrome; IBD inflammatory bowel disease; SBP spontaneous bacterial peritonitis 2 FRIDAY FEBRUARY 26 OVERALL LEARNING OBJECTIVE FOR CDDW™ 2016 At the end of the conference delegates will be able to: 1. Identify evolving new areas of clinical and basic research in gastroenterology and hepatology. 2. Affirm through evaluation of the evidence that knowledge and management strategies are current. 3. Formulate management strategies for patients with gastrointestinal, including liver, disease. 4. Compare and contrast a wide variety of therapeutic approaches in the care of patients with gastrointestinal, including liver, diseases. 5. Recognize the importance of quality measures and patient safety initiatives in clinical and endoscopic practice. 6. Interact with colleagues to foster a community of practice. CAG/CASL POSTGRADUATE COURSE Specialists may be defined by their knowledge of the leading edge issues in gastroenterology and hepatology. The Postgraduate Course is intended to bring you up to date on developments in selected areas and get you ready for the challenges of 2016. 08h00-09h30 CAG/CASL POSTGRADUATE COURSE: Marquette/Jolliet Community-based Gastrointestinal and Liver Disease Learning Objectives: At the end of this session participants will be able to: 1. Review the selection of biologic agents to treat IBD and understand the role of combination therapy. 2. Discuss the time interval of endoscopic surveillance for: IBD-associated neoplasia, colonic polyps, and Barrett’s esophagus. 3. Describe the staging of hepatitis C disease, and explore the role of community gastroenterologists in accessing and implementing new treatments. Co-Chairs: Geoffrey Nguyen, University of Toronto and Kevork Peltekian, Dalhousie University Mirror, Mirror on the Wall, Which Biologic Combo Will Fare Best of All? Brian Bressler, University of British Columbia Timing is Everything: How often should we perform endoscopic surveillance? Marietta Iacucci, University of Calgary Charging the Frontlines: Real world challenges with the new hepatitis C therapy Hemant Shah, University of Toronto – CAG co-developed this program with Bristol-Myers Squibb Canada to achieve scientific integrity, objectivity and balance – 08h00-09h30 †CAG SYMPOSIUM: Mackenzie IBD Microbiota Learning Objectives: At the end of this session participants will be able to: 1. Understand the complexity of dietary-microbiota interactions and the role they play in modulation of intestinal inflammation. 2. Discuss the role of bacterial anti-fungal dysbiosis in IBD. 3. Review the current therapies and levels of evidence regarding therapies targeting the microbiome in IBD. Co-Chairs: Michael Surette, McMaster University and Elena Verdu, McMaster University Diet-Microbiota Interactions in IBD: From basics to clinics Karen Madsen, University of Alberta Beyond Bacterial Dysbiosis: Fungal signature in IBD Frederic Bushman, University of Pennsylvania Microbiota Directed Therapies for IBD: Focus